I am deeply honored to receive the Public Engagement Award 2024 from the @BritPharmSoc presented by Prof. Sir Mark Caulfield. Thank you all for being an integral part of this achievement.

🌟 New Position Statement Alert 🌟 People with resistant hypertension (RH) face a higher risk of serious cardiovascular events. Our latest guidance outlines practical steps to investigate and manage RH effectively. 🔗 Read the full statement:

Good morning, Harrogate! 🌞 The BPS team has arrived in Harrogate, where we’re preparing for doors to open at #Pharmacology2024 tomorrow morning. We can’t wait to see you there!

I am pleased to announce that I have been elected as a fellow of the @BritPharmSoc I am honoured to be elected this year and thank you to everyone who has supported me so far. https://t.co/8OF70wzEas

We are thrilled to support Dr. Lip through our travel grant program and proud of her impactful contributions to cardiovascular research. Read more about her work: https://t.co/bBLNNDzm3h @UofGlasgow @GlasgowBP @drstefanielip

From GWAS to novel mechanism and clinical trial - hypertension precision medicine. New research funded by the British Heart Foundation, and published in the journal Hypertension. Here are the details in 10 tweets. #umod #hypertension #gwas #torasemide https://t.co/XEfNbWMCfO

AHA Scientific Statements: Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association https://t.co/Qhn9fAoiLX

Hypertension & OH is complex @spjuraschek fabulous overview 1. New definitions OH types 2. In some groups we should lower BP 3. Beware the drugs which are worst offenders 4. Start low, go slow, be judicious #BGSconf

Helpful tips for pheochromocytoma @AHAScience @AHAMeetings #Hypertension24 Presented by Dr. Auchus

🎉 #Hypertension24 has come to a close! We loved Chicago hope you did too. See you next September in Maryland for #Hypertension25! 🌟

Hypertension is the leading risk factors for stroke and dementia including Alzheimer's! @AHAScience @AHAMeetings #Hypertension24

Fun debate on Resistant Hypertension to watch now at #Hypertension24 with @jenniferlcluett kicking it off and arguing for Medications, @spjuraschek arguing for lifestyle interventions, and @DebbieCohenMD arguing for renal denervation. Standing room only! @JAHA_AHA @AHAScience

Thank you to @ColinBerryMD @LabTouyz

#Hypertension24 Thank you @AHAScience for the Paul Dudley White International Scholar Award. Excited for my poster presentation this evening on LOCHINVAR @GlasgowBP @heartresearchuk

So happy to be recognised along with my peers at #Hypertension24 for the highest ranked abstract from the UK. I invite you to register and attend the event with me! @AHAScience @American_Heart https://t.co/IYaiaaqPFF @GlasgowBP @UofGSCMH @heartresearchuk

.@NHSGGC staff @NHSGGCPharmacy

Love this! 👩🏽‍⚕️🩺👊🏴󠁧󠁢󠁳󠁣󠁴󠁿

A huge welcome to all the newly qualified doctors joining us across @NHSGGC. You will be great. Remember we are all here to support, teach and help you. Also a massive thanks and best wishes to those moving on to new roles next week.

🔔Important update! The guideline for antibiotic therapy after 4 days of IV gentamicin has been revised. Piperacillin/tazobactam is no longer routinely recommended. Learn more about alternatives in our blog: https://t.co/BYzfMe1u66 #Antibiotics #NHSGGCStaff @NHSGGC

5/ Implementing ML in hypertension management could revolutionise treatment, especially in resource-poor settings. However, ethical deployment requires involving patients, healthcare providers, and stakeholders from the start. The journey is promising but requires careful steps.